Karyopharm Therapeutics Inc. (KPTI) Form 8-K — Nov 5, 2026
Karyopharm Therapeutics received a Nasdaq delisting notice on November 4, 2026, following its November 2 Chapter 11 bankruptcy filing in the Southern District of Texas. Trading will be suspended at the open on November 11, 2026, and shares are expected to move to an OTC market under the symbol KPTIQ. The company will not appeal the delisting, which Nasdaq based on the bankruptcy petitions, concerns about residual equity value, and compliance concerns.
Key figures
- New Ticker
- KPTIQ
- Delisting Notice Date
- 2026-11-04
- Bankruptcy Filing Date
- 2026-11-02
- Trading Suspended Date
- 2026-11-11
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.